Shenzhen Airlines Launches Direct Flight From Shenzhen to Barcelona Successfully
28.8.2023 21:04:00 EEST | Business Wire | Press release
The flight ZH9065 with 203 passengers on board, which took off from Shenzhen of China, landed in Barcelona of Spain in the morning on August 28, marked the new direct flight has been launched successfully by Shenzhen Airlines.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230828849009/en/
Zhou Zhiwei(L6), board member and executive vice president of Shenzhen Airlines, and Hu Aimin(L5), the deputy consul-general of China in Barcelona, welcome the cabin crew and passengers of the debut flight of Shenzhen-Barcelona route in Barcelona on August 28. (Photo: Business Wire)
Together with the Barcelona municipality, the general consulate of China in Barcelona, the Air Routes Development Committee in Barcelona (CDRA), Network of airports in Spain (AENA), the Shenzhen airlines and its partner Air China, organized a warm ceremony to welcome the passengers, while the major of Barcelona, the deputy consul-general of China in Barcelona, and dozens of representatives of those organizers attended the event.
The round flight connecting Shenzhen and Barcelona is operated by Shenzhen Airlines twice a week, on every Monday and Friday. Flight ZH9066 from Barcelona to Shenzhen departs at 11:30 local time and arrives at 07:00 Beijing time, the return flight ZH9065 departs at 11:30 and arrives at 08:05.
The advanced Airbus A330 wide-body passenger aircraft has been invested in this new route, which brings every people a comfortable journey.
In addition, passengers taking this flight are provided with cross-city transfers, free transit hotels, express visa process, and other exclusive services.
Shenzhen Airlines was established in 1992 in Shenzhen, one of the core cities of the Guangdong-Hong Kong-Macao Greater Bay Area in China. With 226 passenger aircraft of various types, the fleet of Shenzhen Airlines ranks the fifth in China. Supporting by 15 branches or bases across the whole country, Shenzhen Airlines operates now more than 200 routes, covering the major destinations in China and abroad.
Shenzhen is one of the five major airports in China, also an important transportation hub in the Asia-Pacific region, plays an important role for connecting China and the other countries.
2023 marks the 50th anniversary of the establishment of diplomatic relations between Spain and China, and the second anniversary of Barcelona and Shenzhen becoming sister cities. The new route sets up a convenient air bridge between the two cities, which will further promote the cooperation between the two places and even between the two nations in the fields of sci-tech, culture, tourism, and trade.
The new route is Shenzhen Airlines' second direct flight from Europe following the first one between London and Shenzhen. Shenzhen Airlines will continue to enrich the route network in near future.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230828849009/en/
Contact information
Z. Pan info@xinhuaeurope.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
VerSprite Launches Fork and Knife: AI-Driven Threat Modeling and Adversarial Testing Built for the Speed of Modern Software27.6.2026 00:28:00 EEST | Press release
VerSprite, a global leader in risk-based threat modeling and the firm behind the PASTA (Process for Attack Simulation and Threat Analysis) methodology, today announced the general availability of Fork (www.forktm.com), a continuous application threat modeling platform, alongside Knife, an AI-led, human-on-the-loop adversarial testing platform for web applications and web API endpoints. Together, the two products operationalize a new model for product security—one where applications are securely designed, continuously modeled, and actively tested as part of the build process itself. The launch addresses a problem every security leader knows but few tools have solved: threat modeling is essential, never more so than in an AI-driven era, yet it has remained slow, manual, and anchored to frameworks designed for a different threat landscape. The problem: threat modeling matters more than ever—and most tools are stuck in 2005 For two decades, application threat modeling has leaned heavily on
Venture Global Announces Closing of $1.5 Billion Senior Secured Vessel Financing Facility26.6.2026 23:30:00 EEST | Press release
Venture Global, Inc. (NYSE: VG) announced today that its wholly-owned subsidiary, Venture Global Shipping Holdings, LLC (“VGSH”), has entered into a Credit and Guaranty Agreement providing for a senior secured term loan facility (the “Facility”) in an aggregate principal amount of up to $1,500,000,000. The Facility will mature on June 26, 2032. Deutsche Bank and ING acted as coordinating lead arrangers for the Facility. ING also serves as facility agent and security trustee. VGSH intends to use the net proceeds from the Facility for general corporate purposes, including to reimburse Venture Global LNG, Inc. for payments previously made by it or its affiliates in connection with the acquisition of nine LNG carriers, funding certain reserve accounts, and paying transaction fees and expenses. About Venture Global Venture Global is an American producer and exporter of low-cost U.S. liquefied natural gas (“LNG”) with over 100 MTPA of capacity in production, construction, or development. Ven
Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 21:00:00 EEST | Press release
Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solution – uses digital twin technology to identify vulnerable customers and recommend explainable next-best actions for fro
Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release
Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o
Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom